153 related articles for article (PubMed ID: 36161220)
1. Protective effect of allopurinol in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Mansoor K; Suliman M; Amro M; Malik S; Amro A; Curtis Z; El-Hamdani M; Ogu I; Aronow WS
Arch Med Sci Atheroscler Dis; 2021; 6():e196-e202. PubMed ID: 36161220
[TBL] [Abstract][Full Text] [Related]
2. Effects of allopurinol pretreatment on the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
.
Xin W; Lin Z; Zhang T; Jia S
Clin Nephrol; 2020 Jan; 93(1):24-33. PubMed ID: 31661061
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
Liu Y; Hong D; Wang AY; Guo R; Smyth B; Liu J; Sun G; Chen S; Tan N; Jardine M; Brieger D; Shaman A; Islam S; Chen J; Gallagher M
BMC Cardiovasc Disord; 2019 Apr; 19(1):87. PubMed ID: 30961544
[TBL] [Abstract][Full Text] [Related]
4. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization.
Kumar A; Bhawani G; Kumari N; Murthy KS; Lalwani V; Raju ChN
J Clin Diagn Res; 2014 Dec; 8(12):HC03-7. PubMed ID: 25653965
[TBL] [Abstract][Full Text] [Related]
6. Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis of randomized controlled trials.
Duan N; Zhao J; Li Z; Dong P; Wang S; Zhao Y; Wang L; Wang H
Med Sci Monit; 2015 Jan; 21():292-7. PubMed ID: 25613017
[TBL] [Abstract][Full Text] [Related]
7. Allopurinol prophylactic therapy and the prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A prospective randomized controlled trial.
Iranirad L; Sadeghi MS; Bagheri A; Doostali K; Norouzi S; Hejazi SF; Saghafi H; Roshani-Mobaraki S
ARYA Atheroscler; 2017 Sep; 13(5):230-235. PubMed ID: 29371869
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Zhao SJ; Zhong ZS; Qi GX; Tian W
Int J Cardiol; 2016 Oct; 221():251-9. PubMed ID: 27404685
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials.
Liang M; Yang S; Fu N
Medicine (Baltimore); 2017 Jul; 96(27):e7384. PubMed ID: 28682890
[TBL] [Abstract][Full Text] [Related]
10. Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials.
Wei XB; Jiang L; Liu XR; Yu DQ; Tan N; Chen JY; Zhou YL; He PC; Liu YH
Eur J Clin Pharmacol; 2016 Nov; 72(11):1311-1318. PubMed ID: 27695914
[TBL] [Abstract][Full Text] [Related]
11. Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review.
Busch SV; Jensen SE; Rosenberg J; Gögenur I
J Interv Cardiol; 2013 Feb; 26(1):97-105. PubMed ID: 23240788
[TBL] [Abstract][Full Text] [Related]
12. Prevention of contrast-induced nephropathy with prostaglandin E1 in patients undergoing percutaneous coronary procedures: A meta-analysis of 24 randomized controlled trials
.
Liu X; Hang Y; Shen L; Yang J; Zhou L; Sha W; Lu G
Clin Nephrol; 2018 Nov; 90(5):313-324. PubMed ID: 30106366
[TBL] [Abstract][Full Text] [Related]
13. [Meta-analysis on efficacy of salvianolate in prevention of contrast-induced nephropathy].
Xi YT; Yuan LY; Xu ST; Liu XY; Wu W
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2616-2626. PubMed ID: 31359732
[TBL] [Abstract][Full Text] [Related]
14. Effect of Nicorandil Administration on Preventing Contrast-Induced Nephropathy: A Meta-Analysis.
Zhan B; Huang X; Jiang L; Bao H; Cheng X
Angiology; 2018 Aug; 69(7):568-573. PubMed ID: 28950711
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
Wu H; Li D; Fang M; Han H; Wang H
J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898
[TBL] [Abstract][Full Text] [Related]
16. Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial.
Ghelich Khan Z; Talasaz AH; Pourhosseini H; Hosseini K; Alemzadeh Ansari MJ; Jalali A
Clin Drug Investig; 2017 Sep; 37(9):853-860. PubMed ID: 28608311
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Trimetazidine in the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Contrast Coronary Intervention: A Systematic Review and Meta-Analysis (PRISMA).
Nair T; Ray S; George J; Pande A
J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610916
[No Abstract] [Full Text] [Related]
18. Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.
Li H; Wang C; Liu C; Li R; Zou M; Cheng G
Am J Cardiovasc Drugs; 2016 Jun; 16(3):201-19. PubMed ID: 26899537
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial.
Erol T; Tekin A; Katırcıbaşı MT; Sezgin N; Bilgi M; Tekin G; Zümrütdal A; Sezgin AT; Müderrisoğlu H
Int J Cardiol; 2013 Aug; 167(4):1396-9. PubMed ID: 22572633
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Effectiveness of Pretreatment With Intravenous Fluid in Reducing the Risk of Developing Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis.
Zaki HA; Bashir K; Iftikhar H; Alhatemi M; Elmoheen A
Cureus; 2022 May; 14(5):e24825. PubMed ID: 35693368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
